NCT03067454

Brief Summary

Spiral metacarpal fractures (metacarpal II-V) can be treated conservatively or with operation. With minimal displacement this fracture is usually treated with immobilisation or early mobilisation. With appreciable displacement especially any malrotation the patient usually is treated with an operation. This usually includes an open reduction of the fracture and fixation with plates and screws or just screws. Even if this is an standard procedure both mild and severe complications have been reported. New studies have shown that even displaced fractures can be treated with early mobilization. In those cases the fractures may heal with some shortening but very good function. An advantage of early mobilization is that the patient avoids the risk of an operation and the costs for the treatment are decreased markedly. The study is designed to answer the question if early mobilization is not inferior to operative treatment but with lower costs and without any operation related risks.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
42

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 21, 2017

Completed
8 days until next milestone

First Posted

Study publicly available on registry

March 1, 2017

Completed
Same day until next milestone

Study Start

First participant enrolled

March 1, 2017

Completed
4.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 28, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 28, 2021

Completed
Last Updated

July 16, 2021

Status Verified

July 1, 2021

Enrollment Period

4.2 years

First QC Date

February 21, 2017

Last Update Submit

July 9, 2021

Conditions

Keywords

early mobilisationmetacarpal fractureoperation

Outcome Measures

Primary Outcomes (1)

  • Grip-strength measured by the JAMAR dynamometer

    Power of the treated hand measured by the JAMAR dynamometer compared with the none-operated hand

    1 year

Secondary Outcomes (5)

  • Handfunction rated by the DASH-score

    1 year

  • Range of motion in the treated hand/fingerray

    1 year

  • Appearance and severity of complications

    1 year

  • Time until the patient can return to work, driving and sport

    1 year

  • The total costs of each treatment

    1 year

Study Arms (2)

conservative group

OTHER

Treatment with early mobilisation

Procedure: Early mobilisation

operative group

OTHER

Treatment with operation

Procedure: Operation

Interventions

Conservative treatment with early mobilisation The patient is instructed to do a fist and is not allowed to leave the clinic before. Active mobilisation under control (doctor or physiotherapist) is performed until healing of the fracture is documented.

conservative group
OperationPROCEDURE

Operation of the fracture. Usually open reduction and internal fixation with plates and screws or just screws within 2 weeks of injury. Immobilisation in a cast for two weeks followed by physiotherapy.

operative group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • single spiral fractures of metacarpal bone II-V
  • fracture line at least twice the length of the diameter of the bone at the level of the fracture
  • at least 1-2mm displacement of the fracture and/or malrotation
  • normal hand function before the injury
  • fracture less than 10 days old

You may not qualify if:

  • multiple metacarpal fractures
  • open fractures
  • incompliance or dementia
  • fracture line not twice the length of the diameter of the bone at the level of the fracture
  • abnormal hand function before the injury
  • fracture more than 10 days old

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Falu lasarett, Department of Orthopedics

Falun, Dalarna County, 79182, Sweden

Location

Uppsala University Hospital, Dept. of Handsurgery

Uppsala, Uppsala County, 75185, Sweden

Location

MeSH Terms

Conditions

Fractures, Bone

Interventions

Surgical Procedures, Operative

Condition Hierarchy (Ancestors)

Wounds and Injuries

Study Officials

  • Nils Hailer, Professor

    Department of Orthopedics, Uppsala University Hospital

    STUDY DIRECTOR
  • Daniel Muder, MD, Dr. med.

    Department of Orthopedics, Falu lasarett

    PRINCIPAL INVESTIGATOR
  • Grey Giddins, M.B.B.Ch. F.R.C.S. (Orth)

    Royal United Hospitals Bath NHS Foundation Trust

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Prospective randomised controlled trial to compare operation and treatment with early mobilisation for metacarpalfractures
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 21, 2017

First Posted

March 1, 2017

Study Start

March 1, 2017

Primary Completion

May 28, 2021

Study Completion

May 28, 2021

Last Updated

July 16, 2021

Record last verified: 2021-07

Data Sharing

IPD Sharing
Will not share

Locations